Abstract P3-10-21: Phase Ib dose-finding study of [177Lu]Lu-NeoB + ribociclib + fulvestrant in patients w/ ER+/HER2- advanced breast cancer (ABC) w/ GRPR expression w/ early relapse from (neo)adjuvant endocrine therapy (ET) or progression on ET + CDK4/6i for ABC
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Debasish Tripathy, Dejan Juric, Sonia Pernas, Francois-Clement Bidard, Ana Sofia Ferreira, Kevin Perraud, Louise Emmett
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411286083